← Back
$DTIL All transactions

PRECISION BIOSCIENCES INC

▼ SELL 10b5-1 Plan

$ Value

$31K

Shares

8,149

Price

$4

Filed

Feb 19

Insider

Name

Kelly John Alexander

Title

Chief Financial Officer

CIK

0001590030

Roles

Officer

Transaction Details

Transaction Date

2026-02-18

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

125,883

Footnotes

Represents the vesting of Restricted Stock Units ("RSUs") on February 17, 2026. | Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. | The sales were effected pursuant to a Rule 10b5-1 plan adopted on January 17, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. | RSUs vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Filing Info

Accession No.

0001628280-26-009803

Form Type

4

Issuer CIK

0001357874

Kelly John Alexander's History

Date Ticker Type Value
2026-02-18 DTIL $31K
2026-02-17 DTIL M $0
2026-02-17 DTIL M $0
2026-01-21 DTIL $61K
2026-01-20 DTIL M
2026-01-20 DTIL M
2026-01-20 DTIL M
2026-01-20 DTIL M $0
2026-01-20 DTIL M $0
2026-01-20 DTIL M $0

Other Insiders at DTIL (90d)

Insider Bought Sold Last
Kelly John Alexander
Chief Financial Officer
2026-02-17
SMITH J. JEFFERSON
Chief Research Officer
$19K 2026-02-18
Scimeca Dario
General Counsel and Secretary
$19K 2026-02-18
Amoroso Michael
President and CEO
$79K 2026-02-18